APIC position paper: Safe injection, infusion, and medication vial practices in health care

American Journal of Infection Control

Volumn 44, Issue 7, 2016, Pages 750-757

  Dolan, Susan A ^a   Arias, Kathleen Meehan ^b   Felizardo, Gwen ^c   Barnes, Sue ^d   Kraska, Susan ^e   Patrick, Marcia ^f   Bumsted, Amelia ^g  

^a Children's Hospital Colorado   (United States)

^b Arias Infection Control Consulting   (United States)

^c Washington State Hospital Association   (United States)

^d KAISER PERMANENTE   (United States)

^e is an assistant professor of nursing at Bethel College   (United States)

^f Infection Prevention Consultant   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

bloodborne; Contaminated; Endoscopy; HCV; Hepatitis C; Outbreak; Syringe

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; ASEPSIS; BLOOD GLUCOSE METER; BLOODBORNE VIRUS; CLINICAL PRACTICE; DISEASE TRANSMISSION; DRUG DOSAGE FORM; GLUCOSE BLOOD LEVEL; HEALTH CARE; HEALTH CARE PERSONNEL; HUMAN; INFECTION CONTROL; INFECTION RISK; INFUSION; INJECTION; INTERNATIONAL NORMALIZED RATIO; MICROBIAL CONTAMINATION; NEEDLE; OPERATING ROOM; PATIENT SAFETY; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRESCRIPTION DRUG DIVERSION; PROKARYOTES BY HABITAT; SYRINGE; VIAL; BLOODBORNE BACTERIUM; CROSS INFECTION; HEALTH CARE FACILITY; INTRAVENOUS DRUG ADMINISTRATION; PREVENTION AND CONTROL; PROCEDURES; TRANSMISSION;

BLOOD-BORNE PATHOGENS; CROSS INFECTION; DISEASE TRANSMISSION, INFECTIOUS; HEALTH FACILITIES; HUMANS; INFECTION CONTROL; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; PATIENT SAFETY; PRACTICE GUIDELINES AS TOPIC;

EID: 84989963898     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2016.02.033     Document Type: Article

References (81)

1. 1 Kuehn, B.M., Unsafe injection practices plague US outpatient facilities, harm patients. JAMA 308 (2012), 2251–2252.
2. 2 Perz, J.P., Thompson, N.D., Schaefer, M.K., Patel, P.R., US Outbreak investigations highlight the need for safe injection practices and basic infection control. Clin Liver Dis 14 (2010), 137–151.
3. 3 Centers for Disease Control and Prevention, Healthcare-associated hepatitis B and C outbreaks reported to the Centers for Disease Control and Prevention (CDC) in 2008-2014. Available from: http://www.cdc.gov/hepatitis/Outbreaks/HealthcareHepOutbreakTable.htm Accessed July 23, 2015.
4. 4 Thompson, N.D., Perz, J.F., Moorman, A.C., Holmberg, S.D., Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Intern Med 150 (2009), 33–39.
5. 5 Centers for Disease Control and Prevention, Transmission of hepatitis B and C viruses in outpatient settings—New York, Oklahoma, and Nebraska, 2000-2002. MMWR Morb Mortal Wkly Rep 52 (2003), 901–906.
6. 6 Outbreak of Hepatitis C at Outpatient Surgical Centers, Public health investigation report. December; Southern Nevada Health District Outbreak Investigation Team, Las Vegas, Nevada; Available from: http://southernnevadahealthdistrict.org/download/outbreaks/final-hepc-investigation-report.pdf, 2009 Accessed July 23, 2015.
7. 7 Centers for Disease Control and Prevention, Investigation of viral hepatitis infections possibly associated with health-care delivery—New York City, 2008-2011. MMWR Morb Mortal Wkly Rep 61 (2012), 333–338 Available from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6119a2.htm Accessed July 23, 2015.
8. 8 Kim, M., Tyson, C., Mascola, L., Outbreak of joint infections associated with magnetic resonance arthrograms performed at an outpatient radiology center. Infect Control Hosp Epidemiol 34 (2013), 1215–1217.
9. 9 Zheteyeva, Y., Tosh, P., Patel, P., Martinez, D., Kilborn, C., Awosika-Olumo, D., et al. Hepatitis B outbreak associated with a home health care agency serving multiple assisted living facilities in Texas, 2008-2010. Am J Infect Control 42 (2014), 77–81.
10. 10 Redd, J.T., Baumbach, J., Kohn, W., Nainan, O., Khristova, M., Williams, I., Patient-to-patient transmission of hepatitis B virus associated with oral surgery. J Infect Dis 195 (2007), 1311–1314.
11. 11 Macedo de Oliveira, A., White, K.L., Leschinsky, D.P., Beecham, B.D., Vogt, T.M., Moolenaar, R.L., et al. An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic. Ann Intern Med 142 (2005), 898–902.
12. 12 Samandari, T., Malakmadze, N., Balter, S., Perz, J.F., Khristova, M., Swetnam, L., et al. A large outbreak of hepatitis B virus infections associated with frequent injections at a physician's office. Infect Control Hosp Epidemiol 26 (2005), 745–750.
13. 13 Schaefer, M.K., Perz, J.F., Outbreaks of infections associated with drug diversion by healthcare personnel, United States. Mayo Clin Proc 89 (2014), 878–887.
14. 14 Watson, J.T., Jones, R.C., Siston, A.M., Fernandez, J.R., Martin, K., Beck, E., et al. Outbreak of catheter-associated Klebsiella oxytoca and Enterobacter cloacae bloodstream infections in an oncology chemotherapy center. Arch Intern Med 165 (2005), 2639–2643.
15. 15 Wiersma, P., Schillie, S., Keyserling, H., Watson, R., De, A., Banerjee, S.N., et al. Catheter-related polymicrobial bloodstream infections among pediatric bone marrow transplant outpatients-Atlanta, Georgia, 2007. Infect Control Hosp Epidemiol 31 (2010), 522–527.
16. 16 Seña, A., Moorman, A., Njord, L., Williams, R., Colborn, J., Khudyakov, Y., et al. Acute hepatitis B outbreaks in two skilled nursing facilities and possible sources of transmission—North Carolina, 2009-2010. Infect Control Hosp Epidemiol 34 (2013), 709–716.
17. 17 Wong, M.R., Del Rosso, P., Heine, L., Volpe, V., Lee, L., Kornbum, J., et al. An outbreak of Klebsiella pneumoniae and Enterobacter aerogenes bacteremia after interventional pain management procedures, New York City, 2008. Reg Anesth Pain Med 35 (2010), 496–499.
18. 18 Centers for Disease Control and Prevention (CDC), CDC Grand Rounds: preventing unsafe injection practices in the U.S. health-care system. MMWR Morb Mortal Wkly Rep 62 (2013), 423–425.
19. 19 Dolan, S.A., Felizardo, G., Barnes, S., Cox, T.R., Patrick, M., Ward, K.S., et al. APIC position paper: safe injection, infusion, and medication vial practices in health care. Am J Infect Control 38 (2010), 167–172.
20. 20 Centers for Disease Control and Prevention, Infection prevention during blood glucose monitoring and insulin administration. Available from: http://www.cdc.gov/injectionsafety/blood-glucose-monitoring.html Accessed July 23, 2015.
21. 21 US Pharmacopeial Convention, Inc, General Chapter <797>: pharmaceutical compounding—sterile preparations. United States Pharmacopeia 38—national formulary 33, 2015, United States Pharmacopeial Convention, Inc., Rockville (MD), 567–611.
22. 22 O'Grady, N.P., Alexander, M., Burns, L.A., Dellinger, E.P., Garland, J., Heard, S.O., et al. Guideline for the prevention of intravascular catheter-related infections. Am J Infect Control 39 (2011), S1–34.
23. 23 Infusion Nurses Society, Infusion nursing standards of practice. J Infus Nurs 34:1 Suppl (2011), S1–110.
24. 24 Food and Drug Administration, Federal Food, Drug, and Cosmetic Act. Section 503A. Pharmacy Compounding; Available from: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm376733.htm Accessed February 23, 2015.
25. 25 Newton, D.W., A review of bacterial and fungal growth rates: implications for urgent-use compounded sterile drugs. October 12; Prepared for the Virginia Board of Medicine; Available from: dnewton@su.edu, 2009.
26. 26 Stucki, C., Sautter, A.M., Favet, J., Bonnabry, P., Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality. Am J Health Syst Pharm 66 (2009), 2032–2036.
27. 27 Bennett, S.N., McNeil, M.M., Bland, L.A., Arduino, M.J., Villarino, M.S., Perrotta, M.P., et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 333 (1995), 147–154.
28. 28 Association of periOperative Registered Nurses, Guidelines for perioperative practice, 2015. IX.a.2 medication safety. 2015, AORN, Inc., Denver (CO).
29. 29 American Society of Anesthesiology, The Joint Commission adopts ASA recommendations on medication management issues. May 17; Available from: http://www.asahq.org/advocacy/fda-and-washington-alerts/washington-alerts/2011/05/the-joint-commission-adopts-asa-recommendations-on-medication-management-issues, 2011 Accessed July 21, 2015.
30. 30 Hicks, R.W., Becker, S.C., Cousins, D.D., MEDMARX Data Report: a chartbook of medication error findings from the perioperative settings from 1998-2005. 2006, US Center for the Advancement of Patient Safety, Rockville (MD).
31. 31 Pugliese, G., Gosnell, C., Bartley, J.M., Robinson, S., Injection practices among clinicians in United States health care settings. Am J Infect Control 38 (2010), 789–798.
32. 32 Association for Safe Aseptic Practice, Aseptic non touch technique (ANTT). Theoretical framework for clinical practice. Available from: http://antt.org/ANTT_Site/Home.html Accessed March 11, 2015.
33. 33 Centers for Disease Control and Prevention, Safe injection practices to prevention transmission of infections to patients. Available from: http://www.cdc.gov/injectionsafety/IP07_standardPrecaution.html Accessed February 23, 2015.
34. 34 Zacher, A.N., Zornow, M.H., Evans, G.J., Drug contamination from opening glass ampules. Anesthesiology 75 (1991), 893–895.
35. 35 Hemingway, C.J., Malhotra, S., Almeida, M., Azadian, B., Yentis, S.M., The effect of alcohol swabs and filter straws on reducing contamination of glass ampoules used for neuraxial injections. Anaesthesia 62 (2007), 286–288.
36. 36 Marks, Z., A needle-free reconstitution and transfer system for compounded sterile intravenous drug solutions in compliance with United States Pharmacopeia Chapter <797> standards. Int J Pharm Compd 18 (2014), 94–99.
37. 37 Danielson, B., Williamson, S., Kaur, G., Brooks, C., Scholl, P., Baker, A., Decreasing the incidence of central line-associated blood stream infections using alcohol-impregnated port protectors in a neonatal intensive care unit. Am J Infect Control 41 (2013), S97–8.
38. 38 DeVries, M., Mancos, P.S., Valentine, M., Evaluating & choosing device to reduce bloodstream infections in both central and peripheral lines. Am J Infect Control, 41, 2013, S40.
39. 39 Stango, C., Stern, J.J., Runyan, D., Macri, I.M., Vacca, M., Riddick, S., et al. Use of alcohol impregnated caps to reduce catheter related bloodstream infections. Am J Infect Control, 41, 2013, S90.
40. 40 Wright, M.O., Tropp, J., Schora, D.M., Dillon-Grant, M., Peterson, K., Boehm, S., et al. Continuous passive disinfection of catheter hubs prevents contamination and bloodstream infection. Am J Infect Control 41 (2013), 33–38.
41. 41 Xu, Y., Zhang, J., Gao, Z., Liu, H., Tian, L., The performance of the microbial barrier of needleless positive pressure closed connectors. Chin J Med Instrum 37 (2013), 365–366.
42. 42 Hong, H., Morrow, D.F., Sandora, T.J., Priebe, G.P., Disinfection of needleless connectors with chlorhexidine-alcohol provides long-lasting residual disinfectant activity. Am J Infect Control 41 (2013), e77–9.
43. 43 Mazher, M.A., Kallen, A., Edwards, J.R., Donlan, R.M., An in vitro evaluation of disinfection protocols used for needleless connectors of central venous catheters. Lett Appl Microbiol 57 (2013), 282–287.
44. 44 Centers for Disease Control and Prevention, One and only campaign. Available from: http://oneandonlycampaign.org/safe_injection_practices Accessed February 23, 2015.
45. 45 Sweet, M.A., Cumpston, A., Briggs, F., Craig, M., Hamadani, M., Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line-associated bloodstream infections and contamination of blood cultures in an inpatient oncology unit. Am J Infect Control 40 (2012), 931–934.
46. 46 Ryder, M., James, G.A., Pulchini, E., Bickle, L., Parker, A.E., Differences in bacterial transfer and fluid path colonization through needle free connector-catheter systems in vitro. Paper presented at; Society for Healthcare Epidemiology of America meeting, Dallas, TX; April 29, 2011.
47. 47 Dolan, S.A., Littlehorn, C., Glode, M.P., Dowell, E., Xavier, K., Nyquist, A.C., et al. Association of Bacillus cereus infection with contaminated alcohol prep pads. Infect Control Hosp Epidemiol 23 (2012), 666–671.
48. 48 The Joint Commission, CLABSI prevention strategies, techniques, and technologies—scrub the hub. The Joint Commission, (eds.) CLABSI toolkit, 2013 Chapter 3; Available from http://www.jointcommission.org/assets/1/6/CLABSI_Toolkit_Tool_3-21_Scrub_the_Hub.pdf Accessed February 23, 2015.
49. 49 Rupp, M.E., Yu, S., Fey, P.D., Van Schooneveld, T., Anderson, J.R., Adequate disinfection of a split-septum needleless intravascular connector with a 5-second alcohol scrub. Infect Control Hosp Epidemiol 33 (2012), 661–665.
50. 50 Simmons, S., Bryson, C., Porter, S., “Scrub the hub”: cleaning duration and reduction in bacterial load on central venous catheters. Crit Care Nurs Q 34 (2011), 31–35.
51. 51 Marschall, J., Mermel, L.A., Fakih, M., Hadaway, L., Kallen, A., O'Grady, N.P., et al. SHEA/IDSA practice recommendation strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 Update. Infect Control Hosp Epidemiol 35 (2014), 753–771.
52. 52 Kaler, W., Chinn, R., Successful disinfection of needleless access ports: a matter of time and friction. J Assoc Vasc Access 12 (2007), 140–142.
53. 53 Moureau, N.L., Flynn, J., Disinfection of needleless connector hubs: clinical evidence systematic review. Nurs Res Pract, 2015, 2015, 796762 Available from http://www.hindawi.com/journals/nrp/2015/796762/ Accessed July 20, 2015.
54. 54 Institute for Safe Medication Practices Safety Alert, ISMP survey reveals user issues with Carpuject prefilled syringes. August 9; Available from https://www.ismp.org/newsletters/acutecare/showarticle.aspx?id=28, 2012 Accessed March 18, 2015.
55. 55 Chernecky, C.C., Macklin, D., Jarvis, W.R., Joshua, T.V., Comparison of central line-associated bloodstream infection rates when changing to a zero fluid displacement intravenous needleless connector in acute care settings. Am J Infect Control 42 (2014), 200–202.
56. 56 Hadaway, L., Needleless connectors for IV catheters. Am J Nurs 112 (2012), 32–44.
57. 57 Wick, C., Slawson, M.H., Jorgenson, J.A., Tyler, L.S., Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am J Health Syst Pharm 60 (2003), 2314–2320.
58. 58 National Institute for Occupational Safety and Health, Preventing occupational exposures to antineoplastic and other hazardous drugs in healthcare settings. 2004, DHHS (NIOSH), Atlanta (GA) Available from http://www.cdc.gov/niosh/topics/antineoplastic/default.html Accessed July 31, 2015; Publication No 2004-165.
59. 59 Rich, D.S., Fricker, M.P. Jr, Cohen, M.R., Levine, S.R., Guidelines for the safe preparation of sterile compounds: results of the ISMP sterile preparation compounding safety summit of October 2011. Hosp Pharm 48 (2013), 282–294.
60. 60 Bader, L., Maydl, G., Gieseke, K., Heesemann, J., Bacterial infections following injections and infusion caused by errors of hygiene—how to avoid them. MMW Fortschr Med 147 (2005), 28–29 31-32.
61. 61 Centers for Medicare & Medicaid Services, Update to Ambulatory Surgical Center (ASC) Infection Control Surveyor Worksheet (ICSW). July 17; Available from http://cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107_exhibit_351.pdf, 2015 Accessed July 31, 2015.
62. 62 Association of Surgical Technologists, Guideline statement for safe medication practices in the perioperative area. Adopted BOD; May; Available from http://www.ast.org/uploadedFiles/Main_Site/Content/About_Us/Guideline_Safe_Medication.pdf, 2005 Accessed July 31, 2015.
63. 63 Verjans, B., Closed vial technology: a new solution to improve sterility assurance levels and to simplify the aseptic filling process. Pharma. The Free Library; Available from http://www.thefreelibrary.com/Closed+vial+technology%3A+a+new+solution+to+improve+sterility+assurance-a0261453104, 2014 Accessed July 31, 2015.
64. 64 Stackhouse, R.A., Beers, R., Brown, D., Brown, M., Greene, E., McCann, M.E., et al. Recommendations for infection control for the practice of anesthesiology. Third ed, 2011, American Society of Anesthesiologists, Park Ridge (IL) Available from http://www.asahq.org/~/media/sites/asahq/files/public/resources/asa%20committees/recommendations%20for%20infection%20control%20for%20the%20practice%20of%20anesthesiology.pdf Accessed July 31, 2015.
65. 65 Centers for Disease Control and Prevention, Medication administration questions. Available from http://www.cdc.gov/injectionsafety/providers/provider_faqs_med-admin.html Accessed July 31, 2015.
66. 66 Abe, K., D'Angelo, M.T., Sunenshine, R., Noble-Wang, J., Cope, J., Jensen, B., et al. Outbreak of Burkholderia cepacia bloodstream infection at an outpatient hematology and oncology practice. Infect Control Hosp Epidemiol 11 (2007), 1311–1313.
67. 67 International Sharps Injury Prevention Society (ISIPS), Sharps Injury Resources. Available from http://www.isips.org/ Accessed July 31, 2015.
68. 68 Centers for Disease Control and Prevention, FAQs regarding safe practices for medical injections. Available from http://www.cdc.gov/injectionsafety/providers/provider_faqs_multivials.html Accessed July 31, 2015.
69. 69 Centers for Disease Control and Prevention, Vaccine storage and handling toolkit. May; p. 1-109; Available from http://www.cdc.gov/vaccines/recs/storage/toolkit/storage-handling-toolkit.pdf, 2014 Accessed July 31, 2015.
70. 70 Counard, C., Perz, J., Linchangco, P., Christiansen, D., Gampva-Raeva, L., Xia, G., et al. Acute hepatitis B outbreaks related to fingerstick blood glucose monitoring in two assisted living facilities. J Am Geriatr Soc 58 (2010), 306–311.
71. 71 Centers for Disease Control and Prevention, Infection prevention checklist for outpatient settings: minimum expectations for safe care. Version 1.0. Available from http://www.cdc.gov/HAI/pdfs/guidelines/ambulatory-care-checklist-07-2011.pdf Accessed July 31, 2015.
72. 72 Thompson, N.D., Perz, J.F., Eliminating the blood: ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies. J Diabetes Sci Technol 3 (2009), 283–288.
73. 73 U.S. Food and Drug Administration, FDA letter to manufacturers of blood glucose monitoring systems listed with the FDA. Available from http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm227935.htm Accessed July 31, 2015.
74. 74 Pérez-Ayala, M., Oliver, P., Cantalejo, F.R., Prevalence of bacterial contamination of glucose test strips in individual single-use packets versus multi-use vials. J Diabetes Sci Technol 7 (2013), 854–862.
75. 75 Institute for Safe Medication Practices, A clinical reminder about the safe use of insulin vials. ISMP Medication Safety Alert! 18 (2013), 1–4 Available from http://www.ismp.org/newsletters/default.asp Accessed July 31, 2015.
76. 76 U.S. Food and Drug Administration, Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens. FDA Alert 3/19/2009; Available from http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm133352.htm, 2009 Accessed July 31, 2015.
77. 77 Institute for Safe Medication Practices, A crack in our best armor: “Wrong patient” insulin pen injections alarmingly frequent even with barcode scanning. ISMP Medication Safety Alert!, 17, 2014, 2 Available from http://www.ismp.org/newsletters/default.asp Accessed July 31, 2015.
78. 78 Institute for Safe Medication Practices, Do not use an insulin pen for multiple patients! Hazard Alert. ISMP Medication Safety Alert! 17 (2012), 1–4 Available from http://www.ismp.org/newsletters/default.asp Accessed July 31, 2015.
79. 79 Centers for Disease Control and Prevention, Use of Hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 60 (2011), 1709–1712.
80. 80 Occupational Safety and Health Administration, Occupational Safety and Health Standards. Bloodborne pathogens. Federal Register 29 CFR 1910.1030; Available from https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=10051 Accessed July 31, 2015.
81. 81 Centers for Disease Control and Prevention, Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 60 (2011), 1–48.